文献速递外周动脉疾病

多学科模式下糖尿病胫动脉病变患者首选腔内治疗的长期结局

Long-term Outcomes of an Endovascular-First Approach for Diabetic Patients With Predominantly Tibial Disease Treated in a Multidisciplinary Setting.
PubMed 文献 · Ann Vasc Surg · 2019-06-12

本研究在多学科肢体保全服务中前瞻性纳入120例糖尿病合并慢性肢体威胁性缺血患者,比较开放手术与腔内治疗(PVI)的围术期及4年结局。结果显示PVI围术期并发症显著更低,虽二期通畅率低于开放手术,但4年无截肢生存率相当。

要点

  • 多学科模式下糖尿病CLTI患者首选腔内治疗,围术期并发症显著低于开放手术。
  • 开放手术4年二期通畅率优于PVI,但无截肢生存率两组相当。
  • 校正基线差异后PVI二期通畅率仍较低,但无截肢生存率无差异。

核心结论

  • 在多学科肢体保全模式下,以胫动脉病变为主的糖尿病CLTI患者首选腔内治疗,其围术期并发症风险低于开放手术。
  • 尽管开放手术的二期通畅率更优,但两种血运重建方式的长期无截肢生存率相当。

研究设计与样本

  • 前瞻性数据库队列研究,纳入2012年6月至2018年7月多学科糖尿病肢体保全服务的患者。
  • 共120例患者接受195次下肢血运重建,其中开放手术53次(27.2%),PVI 142次(72.8%)。
  • 比较围术期(30天)并发症及4年通畅率和保肢率,采用卡方检验、Kaplan-Meier曲线分析和多因素Cox比例风险模型。

主要发现

  • 围术期并发症发生率开放手术组为52.8%,PVI组为12.0%(P < 0.001)。
  • 4年 crude 一期通畅率PVI组34.5 ± 6.6% vs 开放手术组49.6 ± 8.1%(P = 0.89)。
  • 4年二期通畅率开放手术组更优(50.3 ± 7.4% vs 55.4 ± 7.5%,P = 0.04)。
  • 4年无截肢生存率两组相似(65.1 ± 6.7% vs 60.9 ± 9.7%,P = 0.79)。
  • 校正基线差异后,PVI组二期通畅率仍较低(HR 0.35;95%CI 0.14–0.90),但一期通畅率(HR 0.61;95%CI 0.34–1.10)和无截肢生存率(HR 1.51;95%CI 0.71–2.34)无显著差异。

临床怎么用

  • 在多学科糖尿病肢体保全团队中,对以胫动脉病变为主的CLTI患者可优先考虑腔内治疗以降低围术期并发症。
  • 开放手术虽二期通畅率更优,但无截肢生存率与PVI相当,选择术式时应综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Randomized studies suggest that open lower extremity revascularization procedures are associated with improved outcomes compared with endovascular peripheral vascular interventions (PVIs). However, advances in endovascular technologies and treatment by multidisciplinary limb preservation teams have shown improved outcomes. The aim of our study was to compare perioperative and long-term outcomes after open versus PVI procedures in diabetic patients with chronic limb-threatening ischemia (CLTI) treated in a multidisciplinary setting. METHODS: All patients presenting to our multidisciplinary diabetic limb-preservation service from 6/2012 to 07/2018 were enrolled in a prospective database. Patients who underwent either an open lower extremity bypass (LEB) or a PVI for CLTI were included in the analysis. Perioperative (30-day) complications and 4-year patency and limb salvage rates were compared between PVI and LEB using chi-squared tests, Kaplan-Meier curve analyses, and stepwise multivariable Cox proportional hazards models. RESULTS: A total of 195 lower extremity revascularization procedures were performed in 120 patients (mean age: 65.0 ± 1.0 years, 61.7% male, 63.3% black), including 53 (27.2%) open procedures and 142 (72.8%) PVIs. Nearly two-thirds of procedures (65.6%) treated multilevel diseases, while 27.2% treated isolated tibial disease and 7.2% treated isolated femoropopliteal disease. More than half of the procedures (53.3%) were performed for Wound, Ischemia, and foot Infection (WIfI) classification stage 4 limbs, 25.1% for stage 3, and 21.6% for stage 1/2. In the LEB group, 67.9% of targets were infrapopliteal. In the PVI group, 63.4% of procedures were isolated tibial interventions or were multilevel interventions including the tibial segment. Perioperative complications occurred in 52.8% of LEB versus 12.0% of PVI (P < 0.001). At 4 years postoperatively, there was no significant difference in crude (unadjusted) primary patency for PVI versus LEB (34.5 ± 6.6% vs. 49.6 ± 8.1, P = 0.89). Secondary patency was better for the LEB group (50.3 ± 7.4% vs. 55.4 ± 7.5%; P = 0.04), but amputation-free survival was similar (65.1 ± 6.7% vs. 60.9 ± 9.7%; P = 0.79). After adjusting for baseline differences between groups, primary patency (hazard ratio [HR]: 0.61; 95% confidence interval [CI]: 0.34 to 1.10) and amputation-free survival (HR: 1.51; 95% CI: 0.71 to 2.34) remained similar for PVI versus LEB, but secondary patency was persistently lower for PVI (HR: 0.35; 95% CI: 0.14 to 0.90). CONCLUSIONS: In this cohort of diabetic patients with CLTI undergoing predominantly tibial interventions, open revascularization was associated with a higher risk of perioperative complications than PVIs. While secondary patency rates were better after LEBs, our data suggest that an endovascular-first approach results in equivalent long-term amputation-free survival for diabetic patients treated in a multidisciplinary setting.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hicks CW, Canner JK, Lum YW, et al. Long-term Outcomes of an Endovascular-First Approach for Diabetic Patients With Predominantly Tibial Disease Treated in a Multidisciplinary Setting. Ann Vasc Surg. 2019. PMID: 31200047. doi:10.1016/j.avsg.2019.04.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。